Solcoseryl®

Solcoseryl is a calf blood dialysate, that is used as a topical cream to promote wound healing

Brand Meda Pharma GmbH & Co. KG

All payments are SSL encrypted
Full Refund if you haven't received your order
International shipping to the USA, UK and Europe

SOLCOSERYL®, a hemodialysate of calf blood that contains low-molecular-weight blood components such as amino acids, oligopeptides, nucleosides, and glycolipids, was shown to offer a significant cytoprotection in cerebral hypoxic episodes. Specifically, the agent was shown to increase cerebral blood flow, inhibit the development of cytotoxic (6-aminonicotinamid-induced) brain edema, and antagonize the decrement of glucose utilization in limbic areas (cingulate cortex, amygdala, and septal nuclei), the basal ganglia, and the thalamus following stroke in stroke-prone spontaneously hypertensive rats.

Further, S appeared to reduce the formation of free radicals. It had a significant inhibitory effect on the activity of the archidonic cascade and the production of lipid peroxides. A similar preparation, Actovegin®, was reported to increase cerebral metabolism depressed by alcohol and barbiturates and reduce the detrimental effects of an ischemic episode to cortical neurons. Actually, in the hippocampus the ischemia-related reduction of adenosine triphosphate (ATP) and CrP is counterbalanced by Actovegin.

Solcoseryl also used in gel form as a topical wound-healing promoting agent.

Solcoseryl® is marketed under different brands and generic names, and comes in different dosage forms:

Brand name	Manufacturer	Country	Dosage form
Solcoseryl	Meda Pharma GmbH & Co. KG	Switzerland	ointment
Solcoseryl	Meda Pharma GmbH & Co. KG	Switzerland	gel

No customer reviews for the moment.

Write your review

Dosage and Administration

Solcoseryl ointment is applied with a thin layer on the cleaned wound 1-2 times a day, can be applied under dressings. The course of treatment with Solcoseryl ointment continues until the wound is completely healed, its epithelialization and the formation of elastic scar tissue.

For the treatment of severe trophic lesions of the skin and soft tissues, the simultaneous use of parenteral forms of Solcoseryl is recommended.

Adverse reactions

In rare cases, allergic reactions may develop (urticaria, hyperemia and edema at the injection site, increased body temperature). In this case, it is necessary to discontinue the use of the drug and prescribe symptomatic treatment.

Contraindications

Hypersensitivity to one of the components of the drug.

Carefully - with a predisposition to allergic reactions.

Drug interactions

Solcoseryl injections should not be mixed with the introduction of other drugs, especially with phytoextracts.

The pharmaceutical incompatibility of Solcoseryl in the form of a solution for injection with parenteral forms has been established:

extractGinkgo biloba,
Naftidrofuryl,
Bentsiklana fumarata.

As solutions for dilution of Solcoseryl injection, only isotonic sodium chloride solution and 5% glucose solution should be used.

The interaction of Solcoseryl with other drugs of local action is not installed.

Pregnancy and Lactation

The use of Solcoseryl, like all other drugs, is undesirable during pregnancy and lactation and is possible only when absolutely necessary and under the supervision of a physician.

Special instructions

In the event of pain, redness of the skin near the site of application of Solcoseryl, the secretion of secretion from the wound, increase in body temperature, it is urgent to consult a doctor.

If during the application of Solcoseryl, the healing of the affected area is not observed within 2–3 weeks, it is necessary to consult a doctor.